Quantum circuit optimization for arbitrary high-dimensional bipartite quantum computation
New Journal of Physics · 01.04.2026 · 28 (4) · 044502
DOI: 10.1088/1367-2630/ae55be ↗Kurz gefasst
Fachartikel in der Zeitschrift New Journal of Physics, online erschienen am 02.04.2026. Verfasst von Gui-Long Jiang und 1 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Implementation of high-dimensional (HD) quantum gates shows very promising perspectives for HD quantum computation. A bipartite quantum system with arbitrary dimensions n and m is termed a quNit–quMit. Here we propose a synthesis scheme to construct the quantum circuit for general quNit–quMit gates with controlled increment (CINC) gates and local gates. This shows that CINC gates combined with local gates form a universal gate set for HD quantum computation. An upper bound of O ( n 2 ) CINC gates is achieved for arbitrary quNit–quMit gate implementation in the proposed scheme, which is the best known result. Especially for the controlled quNit–quMit gates, our scheme requires only 2 CINC gates, whereas the previous scheme required 2 n .
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Jiang, G., & Wei, H. (2026). Quantum circuit optimization for arbitrary high-dimensional bipartite quantum computation. New Journal of Physics, 28(4), 044502. https://doi.org/10.1088/1367-2630/ae55be
Vancouver
Jiang G, Wei H. Quantum circuit optimization for arbitrary high-dimensional bipartite quantum computation. New Journal of Physics. 2026;28(4):044502. doi:10.1088/1367-2630/ae55be
BibTeX
@article{Jiang2026,
author = {Jiang, Gui-Long and Wei, Hai-Rui},
title = {Quantum circuit optimization for arbitrary high-dimensional bipartite quantum computation},
journal = {New Journal of Physics},
year = {2026},
volume = {28},
number = {4},
pages = {044502},
doi = {10.1088/1367-2630/ae55be}
}
EUVIMED